Bank of New York Mellon’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-59,553
| Closed | -$241K | – | 4364 |
|
|
2023
Q4 | $241K | Hold |
59,553
| – | – | ﹤0.01% | 3888 |
|
|
2023
Q3 | $160K | Hold |
59,553
| – | – | ﹤0.01% | 4009 |
|
|
2023
Q2 | $556K | Buy |
59,553
+7,691
| +15% | +$71.8K | ﹤0.01% | 3520 |
|
|
2023
Q1 | $461K | Buy |
51,862
+8,369
| +19% | +$74.3K | ﹤0.01% | 3529 |
|
|
2022
Q4 | $217K | Buy |
43,493
+349
| +0.8% | +$1.74K | ﹤0.01% | 3934 |
|
|
2022
Q3 | $250K | Buy |
43,144
+4,333
| +11% | +$25.1K | ﹤0.01% | 3919 |
|
|
2022
Q2 | $214K | Buy |
38,811
+9,432
| +32% | +$52K | ﹤0.01% | 4026 |
|
|
2022
Q1 | $338K | Buy |
29,379
+12,219
| +71% | +$141K | ﹤0.01% | 3946 |
|
|
2021
Q4 | $217K | Buy |
+17,160
| New | +$217K | ﹤0.01% | 4244 |
|